The healthcare market faces constant challenges and opportunities. One of the most effective strategies for optimizing resources and improving efficiency is the use of Group Purchasing Organizations (GPOs). This concept has revolutionized purchasing management in the healthcare sector worldwide.  In this article, we will explore the differences and similarities between GPO models in Brazil and the United States.  What are GPOs?  A GPO is an entity that unites multiple institutions or purchasing entities to collectively negotiate purchase contracts with suppliers. The primary goal of GPOs is to achieve economies of scale, allowing participating institutions to purchase products and services at more competitive prices and with better contract terms than they could individually. These organizations are common in sectors such as healthcare, education, government, and industry, facilitating not only cost savings but also product and process standardization and promoting operational efficiency.  GPOs in Brazil  In Brazil, GPOs are in the early stages of development, with no significant noteworthy success stories yet. However, this practice has great potential to transform purchasing management in the healthcare sector.  Brazilian GPOs have everything they need to grow and consolidate in the coming years, and this is why we at Brisa Advisors are thoroughly studying the market and talking with suppliers and buyers to stimulate the growth of this business model.  GPOs in the USA  In the United States, Group Purchasing Organizations (GPOs) are highly developed and play a crucial role in cost management and improving efficiency in the healthcare sector. With a robust infrastructure and a constant focus on innovation and quality, American GPOs are extremely effective in reducing costs and optimizing resources. They serve as an exemplary model for other countries looking to implement or enhance their own group purchasing organizations.  Key Differences and Similarities between Brazil and the USA  Table 1 below offers a clear view of the differences and similarities between GPO models in Brazil and the United States, highlighting key aspects such as structure, benefits, challenges, and impact on the healthcare departament.  Aspect  Brazil  USA  Main Entities  Still nascent, but initiatives like NonStop Import exist  Premier Inc., Vizient, HealthTrust  Adoption and Participation  Growing, voluntary, varying levels of adoption  Widespread, common among private and public institutions  Structure and Operation  Growing, still consolidating  Highly developed and structured  Main Benefits  Cost reduction, quality improvement  Cost reduction, access to products and innovations, additional support  Sustainability of philanthropic and private institutions  Data analysis, benchmarking, supply chain management consulting  Challenges  Regulatory and infrastructure challenges  Contractual complexity, regulatory compliance  Developing collaboration culture  Strict regulatory pressures  Success Stories  Strategic partnerships, cost reduction, efficiency  Substantial savings, improved operational efficiency  Growing interest and participation from hospitals  Standardization of processes and products, knowledge sharing  Sector Impact  Potential to transform healthcare purchasing management  Established model, vital for financial sustainability  Conclusion  In conclusion, the comparison between GPOs in Brazil and the United States reveals significant differences in the development and structure of these organizations. While Brazil is beginning to explore the potential of GPOs through isolated initiatives, the United States has already established a robust and efficient model with well-consolidated GPOs like Premier Inc. and Vizient. Both countries face unique challenges but share the common goal of improving efficiency and reducing costs in the healthcare sector. As we move forward, learning from each country’s experiences can inspire new approaches and international collaborations that further benefit healthcare purchasing management globally.  📢 Let’s Discuss!  What are your experiences with GPOs in the healthcare sector? How do you see the future of group purchasing in Brazil? Share your thoughts and let’s enrich this discussion!  At Brisa Advisors, we are committed to monitoring and analyzing regulatory and market trends shaping the healthcare sector. The evolution of GPOs represents a unique opportunity to positively transform hospital management. Let’s explore together how these strategies can impact the future of healthcare in Brazil and beyond!  Find out more about BPO in RA!  *Budget for registration ownership transfer, Market Access Strategy, and BPO in RA services for your company: www.brisa.com.br 

FIME (Florida International Medical Expo)  is the largest medical device trade show in the Americas, and its importance in the healthcare sector is undeniable. Since its inception, FIME has been a crucial meeting point for healthcare professionals, manufacturers, distributors, and regulators from around the world.  FIME was created with the goal of bringing together the main players in the medical device sector in one place, facilitating the exchange of knowledge, the formation of partnerships, and the presentation of technological innovations. Over the years, the trade show has solidified itself as an essential event for those seeking to be at the forefront of trends and innovations in the medical device market.  This year, FIME will take place from June 19 to 21 in Miami, USA. The 2024 edition promises to be even more impactful, bringing together thousands of exhibitors and visitors from various parts of the world. The trade show offers a unique platform to explore the latest innovations in medical technology, from diagnostic devices to advanced treatment equipment.  At FIME 2024, participants will have the opportunity to:  FIME is a global showcase for the latest innovations in medical technology and an essential meeting point for industry professionals. Do not miss the opportunity to participate in this transformative event and stay abreast of the developments shaping the future of healthcare.  If you wish to introduce your products in Brazil through a strong, competitive, and highly reliable structure, schedule a conversation with our CEO, Marcelo Brisolla, and explore the strategies Brisa Advisors can offer to expand your business in the region.  During FIME, our team will be available to discuss how we can support your company in entering this market, from selecting the best sales channels, obtaining regulatory approvals, to effective commercialization. Schedule a meeting at the trade show and discover how we can collaborate to accelerate the entry of your medical devices into the Brazilian market.  We look forward to seeing you at FIME 2024!  Find out more about BPO in RA!  *Budget for registration ownership transfer, Market Access Strategy, and BPO in RA services for your company: www.brisa.com.br 

The Board of Directors Resolution (RDC) 591/2021, issued by the National Health Surveillance Agency (Anvisa), establishes new guidelines for the identification of medical devices in Brazil through the Unique Device Identification (UDI) system. This resolution marks a significant advancement in the traceability of Class IV risk medical devices. Source: gov.com 2. What does RDC 591/2021 establish? RDC 591/2021 establishes that by July 2024, Class IV risk medical devices must include the UDI on their packaging. Additionally, the resolution defines specific actions to be carried out by companies, such as assigning the UDI, applying the UDI carrier, transmitting information to the UDI database, and including the UDI code in notifications of adverse events, technical complaints, and field actions. 3. What do manufacturers need to do now? It is crucial that manufacturers are aware of the requirements of RDC 591/2021 and act proactively to ensure compliance with the established deadlines. By July 2024, companies must assign and apply the UDI to their Class IV risk medical devices, thereby ensuring precise identification and adequate traceability. Source: gov.com 4. Still have questions on how to proceed? Our experts are available to provide guidance and support throughout the UDI implementation process. Contact us for more information and to ensure compliance with current regulations. Find out more about BPO in RA!  *Budget for registration ownership transfer, Market Access Strategy, and BPO in RA services for your company: www.brisa.com.br